DeepMed Research

DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka

Country: 🇱🇰Sri Lanka

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Risperidone Orally Disintegrating Tablets

First Posted Date: 2010-07-02

Last Posted Date: 2010-07-02

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT01155934

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Citalopram Hydrobromide

First Posted Date: 2010-06-24

Last Posted Date: 2010-06-24

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 24

Registration Number: NCT01149967

Locations: 🇨🇦
Anapharm, Quebec, Canada

Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ibuprofen

First Posted Date: 2010-06-24

Last Posted Date: 2010-06-29

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 30

Registration Number: NCT01149954

Locations: 🇨🇦
Anaphann Inc., Quebec, Canada

Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ibuprofen

First Posted Date: 2010-06-24

Last Posted Date: 2010-06-28

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 30

Registration Number: NCT01149941

Locations: 🇨🇦
Anaphann Inc., Quebec, Canada

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Citalopram Hydrobromide

First Posted Date: 2010-06-24

Last Posted Date: 2010-06-24

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 24

Registration Number: NCT01149980

Locations: 🇨🇦
Anapharm, Quebec, Canada

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Rivastigmine

First Posted Date: 2010-06-17

Last Posted Date: 2012-01-13

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 44

Registration Number: NCT01146067

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Pravastatin Sodium

First Posted Date: 2010-06-17

Last Posted Date: 2012-01-13

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 24

Registration Number: NCT01146093

Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tizanidine

First Posted Date: 2010-06-17

Last Posted Date: 2012-01-13

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 42

Registration Number: NCT01146028

Locations: 🇨🇦
Anapharm Inc., Sainte-Foy (Quebec), Canada

Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Rivastigmine

First Posted Date: 2010-06-17

Last Posted Date: 2010-06-17

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 44

Registration Number: NCT01146041

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Pravastatin Sodium

First Posted Date: 2010-06-17

Last Posted Date: 2010-06-17

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 43

Registration Number: NCT01146106

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy